Why Celyad Oncology (CYAD) stocks rally on Friday?

Highlights The stocks of Celyad Oncology (CYAD) were up over 45% on Friday morning. Fortress Investment invested US$32.5 million in Celyad through...

Longeveron Inc (LGVN) stock’s record rally continues - Know why?

Highlights Longeveron Inc. (NASDAQ: LGVN) stock rallied on Friday as its common stock offering in a private placement draws to a close. Longeveron...

Cumberland (CPIX) stock jumped 100% today – Here’s why

Highlights Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) stock soared more than 100% on Tuesday. The biotechnology company grew by 55% YTD....

HCA Healthcare, Inc. (HCA) stock price, YTD gain – among top perform...

Highlights The HCA Healthcare, Inc. stock gained nearly 40% this year. The stock’s 52-week highest and the lowest stock prices were US$263.92...

First Wave BioPharma (FWBI) stock soars over 36% on upbeat trial dat...

The First Wave BioPharma, Inc. (NASDAQ: FWBI) stock rose more than 36% in the premarket on Tuesday after announcing the data monitoring committee...

Five hot healthcare stocks to watch as Omicron threat looms

Highlights The Florida-based NRX Pharmaceuticals, Inc. develops novel therapeutics for central nervous system disorders and life-threatening pulmon...

Why is Allied Healthcare (AHPI) stock up 53% Friday?

Highlights Stocks of Allied Healthcare Products rallied over 53% in the premarket on Friday. WHO is likely to convene to discuss the spread of a n...

Guess why Moderna (MRNA) stock jumped 23% Friday?

Highlights Moderna’s covid vaccine was found to be most effective among four other drugs in a study. Its vaccine had an effectiveness of 88....

Biofrontera stock (BFRI) rallies 115%, fired up by upbeat rating

Highlights Analysts raised the 12-month stock price target to US$20. The BFRI jumped 115% in intraday trading after the positive comments. The Ma...

Ocuphire Pharma (OCUP) stock jumped 34% - know why?

Highlights Ocuphire Pharma announced the number of participants for the MIRA-3 Phase 3 trial. CEO Mina Sooch said the company will submit a new dr...

Pasithea Therapeutics (KTTA) stock soars 229% - Know why?

Highlights Pasithea Therapeutics' (KTTA) wholly-owned subsidiary Pasithea Clinics got approval for its anti-depressant esketamine nasal spray, SPRA...

Qualigen (QLGN) stock jumped 32% Tuesday – Is it worth the price?

Highlights Qualigen Therapeutics, Inc. (NASDAQ: QLGN) soared 32% in intraday trading on Tuesday. Its third-quarter revenue rose to US$US$1.16 mill...

Aadi Bioscience (AADI) stock soars on FDA approval for FYARRO

Highlights Aadi Bioscience announced FDA approval for its injectable drug FYARRO. FYARRO is the only FDA-approved therapy for advanced malignant P...

Why is iSpecimen Inc. (ISPC) stock making headlines today?

Highlights iSpecimen Inc. (ISPC) said that it secured a contract to support new research on covid. The stocks were up more than 130% on Monday mor...

Why ObsEva SA (OBSV) stock jumped on Monday?

Highlights FDA has agreed to review the new drug application (NDA) for Linzagolix. It has set Sep 13, 2022, as a target date for the NDA review un...

Longeveron (LGVN) shares soared 138%, do you know why?

Highlights FDA has granted rare-pediatric-disease (RPD) designation to Longeveron’s cellular therapy Lomecel-B. Longeveron is currently eval...

Pfizer funding in Cardiff Oncology drives CRDF 21% higher. Know more

Highlights Cardiff Oncology, Inc. (NASDAQ: CRDF) stock jumped 21% in premarket Thursday. The company has received a US$15 million equity investmen...

Dicerna-Novo Nordisk deal revealed: DRNA stock pops 78% in premarket

Highlights Novo Nordisk will acquire Dicerna Pharmaceuticals for US$3.3 billion. After the acquisition, Novo expects to begin the clinical dev...

Progenity (PROG) stock continues rally, up 21%: Here’s why

Highlights Progenity, Inc. (NASDAQ: PROG) will participate in Piper Sandler 33rd Annual Virtual Healthcare Conference The company's revenue surged...

Why did Altamira Therapeutics (CYTO) stock skyrocket today?

Highlights Altamira Therapeutics Ltd. (NASDAQ: CYTO) announces positive test results for Bentrio nasal spray. The company received FDA approval fo...